Search Results 7171-7180 of 34349 for oral

  1. Tongue cancer - Doctors and departments - Mayo Clinic

    Investigating tumor growth factors for oral cancer. Evaluating new methods of use for chemotherapy. Evaluating new radiation therapy regimens. Investigating ...

  2. Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

    Eligible primary tumor locations are oropharynx, oral cavity, hypopharynx, and larynx. Participants must not have received prior systemic therapy for R/M ...

  3. Adult health Maintaining good health - Mayo Clinic

    https://www.ada.org/resources/research/science-and-research-institute/oral-health-topics/whitening. Accessed May 22, 2023. Dental checkups. National Health ...

  4. R. Jeffrey Karnes, M.D. - Doctors and Medical Staff - Mayo Clinic

    First Place, Oral Presentation5th Annual Resident Research Day, Department of Surgery, Southern Illinois University, Springfield, Illinois. 2006. Second Place ...

  5. Pulmonary Medicine - Doctors - Mayo Clinic

    Olson, M.D., M.S.. Rochester, MN. Areas of focus: Facial fracture repair, Rhinoplasty, Oral surgery, Face lift, Glossectomy, Nasal valve repair, Tonsillectomy ...

  6. Nahid Punjani, M.D., M.P.H. - Doctors and Medical Staff - Mayo Clinic

    ReviewerOral Board Study Guide App, American Urological Association. 2025. Abstract ReviewerAmerican Society of Reproductive Medicine. 2025. Grant Reviewer ...

  7. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  8. Publications - Marc Camacho, M.D. - Mayo Clinic

    Eliminating routine oral contrast use for CT in the emergency department: impact on patient throughput and diagnosis. Emerg Radiol. 2012 Dec; 19 (6):513-7 ...

  9. A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of Chronic Spontaneous Urticaria in Adults Inadequately Controlled by H1-antihistamines - Mayo Clinic

    + clopidogrel) is prohibited. - Requirement for anticoagulant medication (for example, warfarin or Novel Oral Anti-Coagulants (NOAC)) - History or current ...

  10. Hodgkin Clinical Trials - Mayo Clinic Research

    Venetoclax is an oral Bcl-2 family protein inhibitor. It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is ...